{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:40:01Z","timestamp":1751521201356,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alexion Pharma","award":["Alexion Pharma"],"award-info":[{"award-number":["Alexion Pharma"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The process of transition from pediatric to adult care is crucial, especially in rare diseases such as lysosomal acid lipase deficiency (LAL-D). Unfortunately, this process is associated with poor outcomes, and many challenges still await to be addressed. This document provides recommendations on the pediatric to adult care transition in patients with LAL-D, based on available evidence and the experience of a panel of experts, which include specialists in the management of patients with LAL-D, and representative patients of the AELALD patient organization. Additionally, the main uncertainties and\/or challenges encountered by the different stakeholders during the process are defined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main body<\/jats:title>\n            <jats:p>A total of 43 consensus recommendations were developed across 5 areas. The consensus recommendations reflect the personal opinions and experiences of the participating experts supported with evidence when available. Overall, the main uncertainties and\/or challenges faced comprise the patient\u2019s mistrust in the new medical team, the insufficient information received, or the lack of time, resources and institutional support. The management of adolescents\/young adults during the transition to adulthood should be a joint effort between the patient, clinical center, and parents\/caregivers. The objective of the transition process should be to empower patients and progressively encourage the self-management of their disease, and therefore patients and their families should be involved in all phases of the transition. Facilitating elements, such as standardized protocols, arose as important tools to ease the transition process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This multidisciplinary consensus provides information on the main obstacles found by patients and their families, pediatricians and adult physicians during the transition from pediatric to adult care in LAL-D. To overcome these barriers, the scientific committee highlights the need for different facilitating elements, which include an effective collaboration between healthcare teams, the elaboration of standardized protocols, the implementation of education for patients, or the individual evaluation of the need for psychological support. The recommendations provided by the experts are the basis to facilitate and improve the transition process.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03852-8","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:55:52Z","timestamp":1751471752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Childhood to adult transition in youth patients with lysosomal acid lipase deficiency: 43 recommendations from experts"],"prefix":"10.1186","volume":"20","author":[{"given":"Alvaro","family":"Hermida-Ameijeiras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Blasco-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"Carrillo-Linares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Gonz\u00e1lez-Dieguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Pastor-Rosado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Morales-Conejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Bellusci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1687-6448","authenticated-orcid":false,"given":"Maria","family":"Mercadal-Hally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"7","key":"3852_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/03007995.2017.1309371","volume":"33","author":"BK Burton","year":"2017","unstructured":"Burton BK, Silliman N, Marulkar S. Progression of liver disease in children and adults with lysosomal acid lipase deficiency. Curr Med Res Opin. 2017;33(7):1211\u20134.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"3852_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","volume":"235","author":"Z Reiner","year":"2014","unstructured":"Reiner Z, Guardamagna O, Nair D, Soran H, Hovingh K, Bertolini S, et al. Lysosomal acid lipase deficiency\u2013an under-recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis. 2014;235(1):21\u201330.","journal-title":"Atherosclerosis"},{"issue":"1","key":"3852_CR3","first-page":"50","volume":"94","author":"M Mar\u00edn-Andr\u00e9s","year":"2021","unstructured":"Mar\u00edn-Andr\u00e9s M, Ros-Arnal I, Cebolla-Sanz JJ, P\u00e9rez-Delgado R, Garc\u00eda-Jim\u00e9nez MC. [Lysosomal acid lipase deficiency: A rarely recognised cause of dyslipidaemia and liver dysfunction]. Pediatr (Engl Ed). 2021;94(1):50\u20131.","journal-title":"Pediatr (Engl Ed)"},{"issue":"11","key":"3852_CR4","first-page":"506","volume":"147","author":"J P\u00e9rez-L\u00f3pez","year":"2016","unstructured":"P\u00e9rez-L\u00f3pez J, Ceberio-Hualde L, Garc\u00eda-Morillo JS, Grau-Junyent JM, Hermida-Ameijeiras A, L\u00f3pez-Rodr\u00edguez M, et al. [Transition process from paediatric to adult care in patients with inborn errors of metabolism. Consensus Statement] Med Clin (Barc). 2016;147(11):506.e1-e7.","journal-title":"Consensus Statement] Med Clin (Barc)"},{"issue":"2","key":"3852_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgme.2019.11.004","volume":"129","author":"R Kohli","year":"2020","unstructured":"Kohli R, Ratziu V, Fiel MI, Waldmann E, Wilson DP, Balwani M. Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: consensus recommendations from an international collaborative working group. Mol Genet Metab. 2020;129(2):59\u201366.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"3852_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/jpepsy\/jsx142","volume":"43","author":"WN Gray","year":"2018","unstructured":"Gray WN, Schaefer MR, Resmini-Rawlinson A, Wagoner ST. Barriers to transition from pediatric to adult care: A systematic review. J Pediatr Psychol. 2018;43(5):488\u2013502.","journal-title":"J Pediatr Psychol"},{"issue":"1","key":"3852_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13023-022-02232-w","volume":"17","author":"D Genevaz","year":"2022","unstructured":"Genevaz D, Arnoux A, Marcel C, Brassier A, Pichard S, Feillet F, et al. Transition from child to adult health care for patients with lysosomal storage diseases in france: current status and priorities-the TENALYS study, a patient perspective survey. Orphanet J Rare Dis. 2022;17(1):68.","journal-title":"Orphanet J Rare Dis"},{"key":"3852_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-023-02698-2","volume":"18","author":"C Grasemann","year":"2023","unstructured":"Grasemann C, H\u00f6ppner J, Burgard P, Sch\u00fcndeln MM, Matar N, M\u00fcller G, et al. Transition for adolescents with a rare disease: results of a nationwide German project. Orphanet J Rare Dis. 2023;18:93.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3852_CR9","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","volume":"123","author":"WS Richardson","year":"1995","unstructured":"Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12\u20133.","journal-title":"ACP J Club"},{"key":"3852_CR10","doi-asserted-by":"publisher","unstructured":"Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI, 2020. Available from https:\/\/synthesismanual.jbi.global. https:\/\/doi.org\/10.46658\/JBIMES-20-01","DOI":"10.46658\/JBIMES-20-01"},{"key":"3852_CR11","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) A guideline developer\u2019s handbook Edinburgh: SIGN; 2019 (SIGN publication no 50) [November 2019] Available from: http:\/\/www.signacuk."},{"issue":"9","key":"3852_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2105\/AJPH.74.9.979","volume":"74","author":"A Fink","year":"1984","unstructured":"Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984;74(9):979\u201383.","journal-title":"Am J Public Health"},{"issue":"1","key":"3852_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pedn.2014.09.015","volume":"30","author":"DE Szalda","year":"2015","unstructured":"Szalda DE, Jimenez ME, Long JE, Ni A, Shea JA, Jan S. Healthcare system supports for young adult patients with pediatric onset chronic conditions: A qualitative study. J Pediatr Nurs. 2015;30(1):126\u201332.","journal-title":"J Pediatr Nurs"},{"key":"3852_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pedn.2020.01.002","volume":"51","author":"A Schmidt","year":"2020","unstructured":"Schmidt A, Ilango SM, McManus MA, Rogers KK, White PH. Outcomes of pediatric to adult health care transition interventions: an updated systematic review. J Pediatr Nurs. 2020;51:92\u2013107.","journal-title":"J Pediatr Nurs"},{"key":"3852_CR15","doi-asserted-by":"publisher","first-page":"e4014","DOI":"10.1590\/1518-8345.6594.4014","volume":"31","author":"L Berghetti","year":"2023","unstructured":"Berghetti L, Danielle MBA, Winter VDB, Petersen AGP, Lorenzini E, Kolankiewicz ACB. Transition of care of patients with chronic diseases and its relation with clinical and sociodemographic characteristics. Rev Lat Am Enfermagem. 2023;31:e4014.","journal-title":"Rev Lat Am Enfermagem"},{"key":"3852_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pedn.2021.04.017","volume":"59","author":"W Gray","year":"2021","unstructured":"Gray W, Dorriz P, Kim H, Partain L, Benekos E, Carpinelli A, et al. Adult provider perspectives on transition and transfer to adult care: A Multi-Specialty, Multi-Institutional exploration. J Pediatr Nurs. 2021;59:173\u201380.","journal-title":"J Pediatr Nurs"},{"issue":"1","key":"3852_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1367493506060203","volume":"10","author":"JE McDonagh","year":"2006","unstructured":"McDonagh JE, Shaw KL, Southwood TR. Growing up and moving on in rheumatology: development and preliminary evaluation of a transitional care programme for a multicentre cohort of adolescents with juvenile idiopathic arthritis. J Child Health Care. 2006;10(1):22\u201342.","journal-title":"J Child Health Care"},{"issue":"5","key":"3852_CR18","first-page":"710","volume":"9","author":"M Sandquist","year":"2022","unstructured":"Sandquist M, Davenport T, Monaco J, Lyon ME. The transition to adulthood for youth living with rare diseases. Child (Basel). 2022;9(5):710.","journal-title":"Child (Basel)"},{"issue":"5","key":"3852_CR19","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00431-022-04385-z","volume":"181","author":"L Pape","year":"2022","unstructured":"Pape L, Ernst G. Health care transition from pediatric to adult care: an evidence-based guideline. Eur J Pediatr. 2022;181(5):1951\u20138.","journal-title":"Eur J Pediatr"},{"key":"3852_CR20","doi-asserted-by":"crossref","unstructured":"de Las Heras J, Almohalla C, Blasco-Alonso J, Bourbon M, Couce ML, de Castro L\u00f3pez MJ et al. Practical recommendations for the diagnosis and management of lysosomal acid lipase deficiency with a focus on Wolman disease. Nutrients. 2024;16(24).","DOI":"10.3390\/nu16244309"},{"issue":"10","key":"3852_CR21","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.5551\/jat.63821","volume":"30","author":"T Torii","year":"2023","unstructured":"Torii T, Taniguchi-Fukatsu A, Kawawaki M, Shimoura Y, Ozaki K. Long-Term nutritional counseling for a patient with lipoprotein lipase deficiency. J Atheroscler Thromb. 2023;30(10):1507\u201315.","journal-title":"J Atheroscler Thromb"},{"issue":"2","key":"3852_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00787-018-1213-1","volume":"29","author":"K Cleverley","year":"2020","unstructured":"Cleverley K, Rowland E, Bennett K, Jeffs L, Gore D. Identifying core components and indicators of successful transitions from child to adult mental health services: a scoping review. Eur Child Adolesc Psychiatry. 2020;29(2):107\u201321.","journal-title":"Eur Child Adolesc Psychiatry"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03852-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03852-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03852-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:02:43Z","timestamp":1751518963000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03852-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3852"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03852-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AHA received speaker fees from Alexion; JBA has nothing to declare; JLCL received fees from Alexion; MLGD received consultant and speaker fees from Alexion; JPR has received conference payments from Astra Zeneca-Alexion; grants for attendance at scientific meetings, as well as fees for scientific consultancy from Astra Zeneca-Alexion; MMC received fees from Alexion and speaker fees from Sanofi, Taketa, Chiesi, Amicus and Biomarin; MB has nothing to declare; MMH received speaker fees from Alexion.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"337"}}